After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Maravai LifeSciences Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Maravai LifeSciences Holdings Inc is $879.63M. A total of 0.7 million shares were traded on the day, compared to an average of 1.49M shares.
In the most recent transaction, Brust Bernd bought 216,212 shares of MRVI for 3.25 per share on Nov 13 ’25. After the transaction, the Chief Executive Officer now owns 466,771 company shares. In a previous transaction on Nov 11 ’25, Brust Bernd bought 157,201 shares at 3.24 per share. MRVI shares that Chief Executive Officer owns now total 157,201.
Among the insiders who bought shares, Brust Bernd acquired of 93,358 shares on Nov 12 ’25 at a per-share price of $3.21. This resulted in the Chief Executive Officer holding 250,559 shares of MRVI after the transaction. In another insider transaction, ORESHACK KURT sold 25,000 shares at $5.03 per share on Jan 31 ’25. Company shares held by the General Counsel now total 167,618.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MRVI has a high of $6.21 and a low of $1.66.
As of this writing, MRVI has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.1. The company reported an EPS of -$0.06 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MRVI’s latest balance sheet shows that the firm has $551.27M in Cash & Short Term Investments as of fiscal 2021. There were $575.22M in debt and $93.78M in liabilities at the time. Its Book Value Per Share was $1.70, while its Total Shareholder’s Equity was $545.36M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRVI is Buy with a score of 3.92.
